Mark W Johnson MD

PubMed

• Pathogenic Mechanisms of Immune Checkpoint Inhibitor (ICI)-Associated Retinal and Choroidal Adverse Reactions.
  Rachana Haliyur, Susan G Elner, Therese Sassalos, Shilpa Kodati, Mark W Johnson
  American Journal of Ophthalmology. 2025-04-01
• Presumed Pentosan Polysulfate Maculopathy With Limited Drug Exposure.
  Jonah E Yousif, Mark W Johnson
  JAMA Ophthalmology. 2025-03-13
• Time-Driven Activity-Based Costing Analysis of Panretinal Photocoagulation.
  Sean T Berkowitz, David L Zhang, Warren W Pan, Osama Ahmed, Cagri G Besirli
  Ophthalmology. Retina. 2025-01-15

Journal Articles

• The value of red targets and pattern-deviation plots in visual field screening for hydroxycholoroquine retinopathy  
  Marmor MF, Chien FY, Johnson MW, JAMA Ophthalmol, 1/1/2013
• Chronic retinal necrosis: CMV necrotizing retinitis associated with panretinal vasculopathy in non-HIV patients  
  Schneider EW, Elner SG, VanKuijk FJ, Goldberg N, Liebermann RM, Eliott D, Johnson MW, Retina, 1/1/2013
• How should we release vitreomacular traction: surgically, pharmacologically, or pneumatically?  
  Johnson MW, Am J Ophthalmol, 1/1/2013
• Treatment of subretinal fluid associated with dome-shaped macula  
  Chinskey ND, Johnson MW, Ophthalmic Surg Lasers Imaging, 1/1/2013
• Stellate neuroretinitis associated with posterior scleritis  
  Goldman DR, Johnson MW, Sarraf D, Retinal Cases Brief Reports, 1/1/2012
• Pars plana vitrectomy without adjuvant procedures for repair of primary rhegmatogenous retinal detachment  
  Schneider EW, Geraets RL, Johnson MW, Retina, 1/1/2012
• Change in choroidal thickness after chemotherapy in leukemic choroidopathy  
  Bajenova NV, VanderBeek BL, Johnson MW, Retina, 1/1/2012
• The diversity of traction mechanisms in myopic traction maculopathy  
  VanderBeek BL, Johnson MW, Am J Ophthalmol, 1/1/2012
• Diagnostic and therapeutic challenges (relentless choroidal lesions)  
  Tranos PG, Moore A, Pavesio C, Acharya NR, Johnson MW, Retina, 1/1/2012
• Traction-induced foveal damage predisposes eyes with pre-existing posterior vitreous detachment to idiopathic macular hole formation  
  Besirli CG, Johnson MW, Eye, 1/1/2012
• Enzymatic vitreolysis with ocriplasmin for vitreomacular traction with macular holes  
  Stalmans P, Benz MS, Gandorfer A, et al, for the MIVI-TRUST Study Group, New Eng J Med, 1/1/2012
• Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two year results  
  CATT Research Group, Martin DF, Maguire MG, et al, Ophthalmology, 1/1/2012
• Vitreomacular disorders: Pathogenesis and treatment  
  Johnson MW, Brucker AR, Chang S, Gandorfer A, Kampik A, Kuppermann BD, Russell SR, Spaide RF, Thompson JT, Retina, 1/1/2012
• Posterior vitreous detachment: evolution and role in macular disease  
  Johnson MW, Retina, 1/1/2012
• Myopic traction maculopathy: pathogenic mechanisms and surgical treatment  
  Johnson MW, Retina, 1/1/2012
• Ocriplasmin update: safety, efficacy, and usage  
  Roach L, Dugel PU, Johnson MW, Schwartz SD, Eyenet, 1/1/2012
• Ocriplasmin offers a nonsurgical VMA treatment option  
  Johnson MW, Rogers A, Martidis A, Thompson JT, Retina Times, 1/1/2012
• Minimalist PPV repair favorable: Approach to primary rhegmatogenous detachment found successful in case series  
  Johnson MW, Ophthalmology Times, 8/1/2011
• Anti-retinal pigment epithelium antibodies in acute exudative polymorphous vitelliform maculopathy: A new hypothesis about disease pathogenesis  
  Koreen L, He S, Johnson MW, Hackel R, Khan N, Heckenlively JR, Arch Ophthalmol, 1/1/2011
• Baseline predictors of visual acuity and retinal thickness outcomes in patients with retinal vein occlusion: SCORE study report 10  
  Scott IU, VanVeldhuisen PC, Oden NL, Ip MS, Blodi BA, Hartnett ME, Cohen G for the SCORE Study Investigator Group, Ophthalmology, 1/1/2011
• Combined cilioretinal artery and central retinal vein occlusions in juvenile glaucoma  
  Zhang L, Sun Y, Johnson MW, Richards JE, Moroi SE, Arch Ophthalmol, 1/1/2011
• Evolving strategies in the management of submacular hemorrhage associated with choroidal neovascularization in the anti-VEGF era  
  Todorich B, Scott IU, Flynn HW, Johnson MW, Retina, 1/1/2011
• Diagnostic and therapeutic challenges (macular retinoschisis)  
  Zaidi AA, Brucker AJ, Johnson MW, Retina, 1/1/2011
• Ranibizumab and bevacizumab for neovascular age-related macular degeneration  
  CATT Research Group, NEJM, 1/1/2011
• Emerging nonsurgical methods for the treatment of vitreomacular adhesion: A review  
  Schneider EW, Johnson MW, Clin Ophthalmol, 1/1/2011
• Join now to see all